These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8996452)

  • 21. Toxoid vaccine for pertussis.
    He Q; Viljanen MK; Arvilommi H; Mertsola J
    Lancet; 1997 Jan; 349(9045):136-7; author reply 137-8. PubMed ID: 8996451
    [No Abstract]   [Full Text] [Related]  

  • 22. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.
    Gabutti G
    J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533
    [No Abstract]   [Full Text] [Related]  

  • 25. Diphtheria, tetanus, and pertussis: Guidelines for vaccine prophylaxis and other preventive measures. Immunization Practices Advisory Committee, Centers for Disease Control.
    Ann Intern Med; 1981 Dec; 95(6):723-8. PubMed ID: 6272621
    [No Abstract]   [Full Text] [Related]  

  • 26. [EFFECT OF TOXOIDS ON THE IMMUNOGENIC VALUE OF THE PERTUSSIS COMPONENT].
    TUROWSKI G
    Med Dosw Mikrobiol; 1963; 15():331-5. PubMed ID: 14118921
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nervous system disorders in AKDS-vaccination].
    Dadiomova MA
    Pediatriia; 1972 Feb; 51(2):25-8. PubMed ID: 5036293
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunization activities.
    Farrington PH
    J Ark Med Soc; 1973 Dec; 70(7):250-1. PubMed ID: 4272004
    [No Abstract]   [Full Text] [Related]  

  • 29. Paralytic poliomyelitis following inoculation with combined diphtheria-tetanus-pertussis prophylactic. A review of sixteen cases with special reference to immunisation schedules in infancy.
    Basu SN
    J Indian Med Assoc; 1973 Feb; 60(3):97-9. PubMed ID: 4720095
    [No Abstract]   [Full Text] [Related]  

  • 30. Acellular pertussis vaccines for infants.
    Edwards KM; Decker MD
    N Engl J Med; 1996 Feb; 334(6):391-2. PubMed ID: 8538712
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial.
    Taranger J; Trollfors B; Knutsson N
    Dev Biol Stand; 1997; 89():109-12. PubMed ID: 9272340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-whooping cough vaccination. Contribution of a case series].
    Borselli L; Giraldi P
    Minerva Pediatr; 1988 Feb; 40(2):91-7. PubMed ID: 3260328
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
    Sato H; Sato Y
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pertussis immunization.
    Simon FA
    Pediatrics; 1979 Sep; 64(3):387-8. PubMed ID: 481986
    [No Abstract]   [Full Text] [Related]  

  • 37. Simultaneous administration of live attenuated measles vaccine with DTP vaccine.
    McBean AM; Gateff C; Manclark CR; Foster SO
    Pediatrics; 1978 Sep; 62(3):288-93. PubMed ID: 704197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic evaluation of a pertussis toxoid vaccine.
    Robbins JB; Trollfors B; Taranger J; Lagergård T; Zachrisson G; Isacson J
    Dev Biol Stand; 1991; 73():297-303. PubMed ID: 1778322
    [No Abstract]   [Full Text] [Related]  

  • 39. [Vaccination in childhood].
    Spiess H
    Dtsch Med Wochenschr; 1972 Jan; 97(4):125-31. PubMed ID: 4550326
    [No Abstract]   [Full Text] [Related]  

  • 40. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.
    Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K
    J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.